Sennosides
- Product NDC
- 37808-712
- 11-digit product format
- 378080712
- Labeler code
- 37808
- Product ID
- 37808-712_46537594-decb-ce80-e063-6394a90aa159
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- H E B
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-07-31
- Substance
- SENNOSIDES
- Active strength
- 17.2 mg/17.21
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 37808-712-10 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 37808-712-10 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 37808-712-10 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 37808-712-10 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 37808-712-10 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sennosides
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES | 17.2 mg/17.21 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3FYP5M0IJX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2169295 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a5652d5b-43fd-5bfa-e053-2995a90aad6c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| baf7f49c-75b6-496b-a00e-8e766a8e4f03 | Product name | 1 | 20210127 |
| ebc62596-fc97-4d03-9483-7ba095d25db7 | Product name | 1 | 20151210 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2025-03-20 | Senna Softgels SENNOSIDES 17.2 mg / LAXATIVE EXTRA STRENGTH |
| 2025-01-30 | Senna Softgels SENNOSIDES 17.2 mg / LAXATIVE EXTRA STRENGTH |
| 2023-03-02 | Senna Softgels SENNOSIDES 17.2 mg / LAXATIVE EXTRA STRENGTH |
| 2023-01-30 | Senna Softgels SENNOSIDES 17.2 mg / LAXATIVE EXTRA STRENGTH |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 37808-712-10 | Sennosides | 100 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Well at Walgreens Castor Oil | CASTOR OIL | Walgreen Co. | e41f8553-3812-4d0b-95f8-20b261279299 | 2026-02-12 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Walgreen Co. | b5a02809-6e01-4e01-b1c3-2b10c5091a4e | 2026-02-12 | Warnings, Adverse reactions | M007 |
| Mineral Oil | MINERAL OIL | Walgreen Co. | 822fd02a-92b0-4010-8bfb-737dba331d54 | 2026-02-12 | Warnings, Adverse reactions | M007 |
| MILK OF MAGNESIA MINT | MAGNESIUM HYDROXIDE | Rugby Laboratories | 5fd89979-903e-4b31-872d-3b8974af3a6b | 2026-02-09 | Warnings | M007 |
| Epsom Salt | EPSOM SALT | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 1845ea0c-0cb6-482b-abe6-fa17785c5b90 | 2026-02-09 | Warnings | M007 |
| Colace Fast-Acting Saline Laxative | MAGNESIUM HYDROXIDE | Atlantis Consumer Healthcare, Inc. | 572adfaf-6e26-42e5-b65d-6d356a0bdfa9 | 2026-02-06 | Warnings | M007 |
| Castor Oil | CASTOR OIL | Retail Business Services, LLC | 4e9c41fa-f240-4986-bb13-541bfeb0e50b | 2026-02-06 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Retail Business Services, LLC | f3661952-ef4f-4f29-93e6-ec09b8464365 | 2026-02-06 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Retail Business Services, LLC | 2f6e9f87-4bff-482b-a54f-f51ca99aac8c | 2026-02-06 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Retail Business Services, LLC | 1a8b540c-b66e-4dca-b7af-23705ae247b6 | 2026-02-06 | Warnings, Adverse reactions | M007 |
| Mineral Oil | MINERAL OIL | Retail Business Services, LLC | b0abcdf9-c226-424f-8970-c2135708c6c8 | 2026-02-06 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Publix Super Markets, Inc. | e985e071-5541-456e-ae4d-dba85287fe75 | 2026-02-05 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | Discount Drug Mart | a82a4aa9-c8af-4383-9d92-ba6c596f0095 | 2026-02-04 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Discount Drug Mart | b05a94d2-5cc6-4989-9fb8-096e54fa7852 | 2026-02-04 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Grocery Outlet, Inc. | 3dff4b00-e71a-1dc0-e063-6394a90a715f | 2026-02-04 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | HARRIS TEETER | 73065a04-b7cd-437d-9624-f845f5ec93bf | 2026-02-04 | Warnings, Adverse reactions | M007 |
| Harris Teeter | MINERAL | Harris Teeter | 401e3a7e-54be-47cc-88c3-a343f5cbbd10 | 2026-02-04 | Warnings, Adverse reactions | M007 |
| Magnesium Citrate | MAGNESIUM CITRATE | Hy-Vee, Inc. | 45374a86-80a4-481c-e063-6294a90a381a | 2026-02-04 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Hy-Vee, Inc. | 44592ee0-13dd-57b1-e063-6394a90ab402 | 2026-02-04 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | CVS Pharmacy, Inc. | a78d991a-ba21-4bc4-b8f9-f8dafbddc28f | 2026-02-03 | Warnings, Adverse reactions | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2169295 | sennosides 17.2 MG Oral Capsule | PSN | a5652d5b-43fd-5bfa-e053-2995a90aad6c | 7 |
| 2169295 | sennosides, USP 17.2 MG Oral Capsule | SCD | a5652d5b-43fd-5bfa-e053-2995a90aad6c | 7 |
| 2169295 | sennosides 17.2 MG Oral Capsule | SY | a5652d5b-43fd-5bfa-e053-2995a90aad6c | 7 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 37808-712-10 | 37808071210 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (37808-712-10) | 2020-07-31 | 0000-00-00 | No | No | Current |